Skip to main content
Impact BioMedical, Inc. (IBO)
Impact BioMedical will go public soon, but the exact IPO date is still unknown.
IPO Price Range
$3.00 - $5.00
Shares Offered
1,500,000
Deal Size
$6.00M

Impact BioMedical Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year
 20222021
Net Income
-7.05-1.3
Depreciation & Amortization
1.111.11
Other Operating Activities
3.9-1.29
Operating Cash Flow
-2.24-2.03
Capital Expenditures
-0.28-
Change in Investments
-0.07-9.46
Investing Cash Flow
-0.35-9.46
Debt Issued / Paid
2.5511.46
Financing Cash Flow
2.5511.46
Net Cash Flow
-0.04-0.03
Free Cash Flow
-2.52-2.03
Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).